AzTrials
AzTrials

PostPartum DepressionBeAMomNCT03024645

Be a Mom: Effectiveness of a Web-based Preventive Intervention for Postpartum Depression

A study testing Be A Mom and Treatment as usually (TAU) in people with PostPartum Depression, run by University of Coimbra at 1 site in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main goal of the research is to apply and evaluate the web-based preventive intervention (the Be a Mom program), in terms of its efficacy, acceptability and feasibility (user's adherence, dropout), and user's satisfaction. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
PostPartum Depression
What is being tested?
Be A Mom and Treatment as usually (TAU)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
1 sitePortugal
Study dates
1 Aug 2017to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

None listed.

Who cannot join

  • Current diagnosis of serious mental health condition (substance abuse, bipolar disorder);
  • Currently receiving treatment for depressive symptoms, including antidepressant medication or psychotherapy;
  • Language difficulties that impede comprehension/reading-writing;
  • All participants will be informed that they will be randomized to one of the study groups and that will only be included if they give informed consent to participate in the study.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Ana Fonseca

    Coimbra, 3000

Other trials in Portugal

About this study

Official title: Be a Mom: A Randomized Controlled Trial of the Effectiveness of a Web-based Preventive Intervention for Postpartum Depression.

The main goal of the research is to apply and evaluate the web-based preventive intervention (the Be a Mom program), in terms of its efficacy, acceptability and feasibility (user's adherence, dropout), and user's satisfaction. Prior to the randomized controlled trial (RCT), the investigators will conduct a pilot trial to evaluate the preliminary version of the Be a Mom program in high-risk women (random assignment to the intervention or to the control condition).

The RCT will be a two-arm prevention trial. Women who have had a child during the prior month will be enrolled in the study. A minimum number of 1000 women will be enrolled in the study. After agreeing to participate in the study, the women will be screened for the presence of risk factors for PPD and early-onset PPD symptoms (using self-report questionnaires) by a researcher (licensed psychologist). In case of a negative screen, women's participation in the study will end. In case of a positive screen (high-risk women), women will be randomly assigned to one of the conditions: the intervention (Be a Mom program) or the control condition. The sample will be recruited online and at the maternities of Coimbra University Hospitals-CHUC, EPE.

Participation in the study will last 11 months. The Be a Mom program will last 5 weeks. Participants in both conditions will be invited by the researchers via email to complete baseline, post-intervention and follow-up (4-months and 12-months after childbirth) assessments. Assessments will include self-report questionnaires to assess several indicators (e.g., depressive and anxiety symptoms, dyadic adjustment, mother-child bonding, and maternal confidence), mechanisms that may be involved in the treatment response (e.g., npsychological flexibility, emotional regulation) and user's acceptability and satisfaction.

Read the detailed description

In the present study, a web-based intervention to prevent PPD (the Be a Mom program) will be tested. The design and content development of the Be a Mom program was conducted through a formative evaluation process (including a systematic literature review about the characteristic and content of existing effective preventive interventions for PPD and a focus group with stakeholders to identify the perceived needs of the target population.

Be a Mom is self-guided intervention grounded on CBT principles, and besides addressing the key topics in the prevention of depression, it also addresses key content areas that are associated with risk for PPD (e.g., communication skills that may help women to manage the transition to motherhood). Moreover, it also includes recent developments in acceptance and commitment based-therapies, specifically for the perinatal context. Be a Mom has a modular set-up that is updated weekly, with each module addressing one or two specific thematic contents (Changes and reorganizations during the transition to parenthood; Emotional diversity; Cognitions; Relationship with others [social support and communication]; Couple relationship; Signs and symptoms of depression and help-seeking). In each module, participants will be provided with both psychoeducational content and therapeutic strategies. Informational material will be given in text format, combined with audio, video and/or animations. The Be a Mom program will also include interactive tools and feedback tools to support learning.

The Be a Mom program will be delivered during the postpartum period, as this was identified as privileged time for the implementation of preventive approaches for PPD. Moreover, the Be a Mom program is recommended to target high-risk women (i.e., women who present antenatally identified risk factors for PPD or with early-onset depressive symptoms).

The main goal of the research is to apply and evaluate the web-based preventive intervention (the Be a Mom program), in terms of its efficacy, acceptability and feasibility (user's adherence, dropout), and user's satisfaction. The efficacy of the program will be assessed considering two indicators: a) absence of clinically significant depressive symptoms at post-intervention and throughout the first postpartum year; and b) post-intervention and follow-up improvements in mother's psychosocial adjustment indicators (anxiety symptoms, maternal confidence and dyadic adjustment). The present study will also aim to investigate the mechanisms explaining the treatment response (e.g., negative automatic thoughts, psychological flexibility, self-compassion).

The research design of the trial followed the methodological recommendations for the development and evaluation of web-based interventions. Prior to the randomized controlled trial (RCT), a pilot trial to evaluate the preliminary version of the Be a Mom program will be conducted. The pilot study will be conducted with women presenting high-risk for PPD or early-onset depressive symptoms (assessed one-month postpartum through self-report questionnaires). The investigators will randomly assign high-risk women to the intervention (the Be a Mom program) or to the control condition, and women will be assessed at baseline and post-intervention concerning adjustment outcomes, acceptability, feasibility and user's satisfaction. After completing the assessments, the control group will be provided with the Be a Mom program. The sample will be collected at the Maternity Daniel de Matos and Maternity Bissaya Barreto (both maternities of Coimbra University Hospitals -CHUC, EPE) and online. Data collection methods will include several self-administered questionnaires. Based on research results the modifications will be identified and conducted to develop the final version of the Be a Mom program, allowing for further efficacy studies.

The RCT will be a two-arm prevention trial, conducted in high-risk women (i.e., presenting risk factors for PPD and/or early-onset postpartum depressive symptoms). The intervention condition (the Be a Mom program) will be compared with a control condition (Treatment as Usual). The sample will include women who delivered an healthy baby in the early postpartum period (up to 3 months postpartum). Women will be enrolled both online and at the maternities of Coimbra University Hospitals -CHUC, EPE. A minimum number of 150 women per condition will be required (N=300). Accounting for the proportion of high-risk and low-risk women and the 50% of attrition rate over time, an anticipated sample of 1000 women will be enrolled in the study.

A researcher (licensed psychologist) will conduct an interview with women who demonstrate interest in the study, aiming to explain the study goals, the structure and arms of the research and the researchers' and participants' roles. Women who agree to participate in the study will sign an informed consent form. All ethical requirements for research with humans are guaranteed.

After women's agreement to participate in the study, the researcher (licensed psychologist) will screen women for the presence of risk factors for PPD and early-onset PPD symptoms (using self-report questionnaires). In case of a negative screen, women's participation in the study will end. In case of a positive screen, high-risk women will be randomly assigned (blocked randomization, with allocation concealment) to one of the conditions: the intervention (Be a Mom program) or the control condition. The randomization will be conducted by a different researcher who will be blind to the assessment procedure.

Participation in the study will last 11 months. The Be a Mom program will last 5 weeks. Participants in both conditions will be invited via email to complete baseline, post-intervention and follow-up (4-months and 12-months after childbirth) assessments. Assessments will include self-report questionnaires to assess several indicators (e.g., depressive and anxiety symptoms, dyadic adjustment, mother-child bonding, and maternal confidence), mechanisms that may be involved in the treatment response (e.g., psychological flexibility, emotional regulation) and user's acceptability and satisfaction. The necessary statistical analyses will be conducted, using the intention-to-treat principles.

Being tested
Be A Mom, Treatment as usually (TAU)
Keywords
Postpartum Depression, Cognitive-Behavioral Therapy, Prevention, Web-Based Psychological Intervention
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Be A MomBehavioural

    The Be a Mom program is a web-based self-guided cognitive-behavioral intervention to prevent postpartum depression, targeting postpartum women. It consists of 5 weekly modules, each module targeting a specific thematic content, and providing women with both information and specific therapeutic strategies (with a strong focus on cognitive-behavioral techniques) to address each thematic content. Modules are sequential.

  • Treatment as usually (TAU)Other

    performed in primary care settings

Study groups in NCT03024645
Study groupRoleWhat they receive
BeAMomExperimentalHigh-risk (HR) women will receive a web-based preventive intervention for PPD (the Be a Mom program). In addition, women will receive postpartum and and pediatric treatment as usually performed in primary care settings (TAU).
Receives: Behavioral: Be A Mom; Other: Treatment as usually (TAU)
ControlActive comparatorHigh-risk (HR) women will receive postpartum and pediatric treatment as usually performed in primary care settings (TAU). During medical appointments, health professionals may ask women and provide information about psychological problems during the postpartum period.
Receives: Other: Treatment as usually (TAU)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of women with clinically significant postpartum depressive symptoms (EPDS > 12) at 4 months postpartum

    Measured with EPDS

    Measured: 4 months postpartum

  2. Number of women with clinically significant postpartum depressive symptoms (EPDS > 12) at 12 months postpartum

    Measured with EPDS

    Measured: 12 months postpartum

  3. Changes from baseline in the severity of depressive symptoms

    Measured with EPDS

    Measured: From baseline to 12 months postpartum

Secondary outcomes (13)
  1. Changes from baseline in anxiety symptoms

    Measured with Anxiety Subscale of HADS

    Measured: From baseline to 12 months postpartum

  2. Changes from baseline in quality of life

    Measured with EQ-5D

    Measured: From baseline to 12 months postpartum

  3. Changes from baseline in dyadic adjustment

    Measured with Dyadic Adjustment Scale - Revised

    Measured: From baseline to 12 months postpartum

  4. Changes from baseline in maternal confidence

    Measured with the Parental Confidence Questionnaire

    Measured: From baseline to 12 months postpartum

  5. Changes from baseline in the frequency of negative automatic thoughts

    Measured with the Postnatal Negative Thoughts Questionnaire

    Measured: From baseline to 12 months postpartum

  6. Changes from baseline in psychological flexibility

    Measured with the Acceptance and Action Questionnaire-II

    Measured: From baseline to 12 months postpartum

  7. Changes from baseline in self-criticism and self-compassion

    Measured with the Self-Compassion Scale (short form)

    Measured: From baseline to 12 months postpartum

  8. Changes from baseline in emotional regulation

    Measured with the Difficulties in Emotional Regulation Scale

    Measured: From baseline to 12 months postpartum

  9. Acceptability of the program for postpartum women

    Measured through specific questions (to be developed by the researchers) to assess acceptability.

    Measured: Measured at post-intervention (2,5 months postpartum)

  10. Feasibility of the program for postpartum women as measured by number of website logins

    Measured through the number of user's website logins.

    Measured: Measured at post-intervention (2,5 months postpartum).

  11. Feasibility of the program for postpartum women as measured by website average visit length

    Measured through the number of user's website average visit length.

    Measured: Measured at post-intervention (2,5 months postpartum).

  12. Feasibility of the program for postpartum women as measured by number of exercises completed

    Measured through the total number of exercises completed by the users.

    Measured: Measured at post-intervention (2,5 months postpartum).

  13. Feasibility of the program for postpartum women as measured by dropout rate.

    Measured through the number of users that dropped out from the web-based intervention before completing it.

    Measured: Measured at post-intervention (2,5 months postpartum).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jan 2017 (estimated)
  2. Study start1 Aug 2017
  3. Primary completion1 Sep 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03024645
Sponsor's protocol ID
CINEICC-2-BaM
Other IDs
SFRH/BPD/93996/2013
Acronym
BeAMom
Status last verified
Apr 2021
First submitted
19 Dec 2016
Last updated
27 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: After the conclusion of the trial, the investigators plan to share the results of the study both with scientific community and health professionals.

Publications

  • Fonseca, A., Pereira, M., Araújo-Pedrosa, A., Gorayeb, R., & Canavarro, M. C. (2016, november). Web-based preventive intervention for postpartum depression: Development and formative evaluation of a CBT intervention. Poster presented at the IX International Congress and XIV National Congress in Clinical Psychology, Santander, Spain. https://www.researchgate.net/publication/311733757_Web-based_preventive_intervention_for_postpartum_depression_Development_and_formative_evaluation_of_a_CBT_intervention

  • Fonseca, A., Pereira, M., Araújo-Pedrosa, A., Moura-Ramos, M., Gorayeb, R., & Canavarro, M. C. (in press). Be a Mom: Formative evaluation of a web-based psychological intervention to prevent postpartum depression. Cognitive and Behavioral Practice. doi:10.1016/j.cbpra.2018.02.002

  • Carona C, Pereira M, Araujo-Pedrosa A, Canavarro MC, Fonseca A. The Efficacy of Be a Mom, a Web-Based Intervention to Prevent Postpartum Depression: Examining Mechanisms of Change in a Randomized Controlled Trial. JMIR Ment Health. 2023 Mar 17;10:e39253. doi: 10.2196/39253.

    PubMed 36930182

Questions about this trial

What is this clinical trial studying?

A study testing Be A Mom and Treatment as usually (TAU) in people with PostPartum Depression, run by University of Coimbra at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of women with clinically significant postpartum depressive symptoms (EPDS > 12) at 4 months postpartum (time frame: 4 months postpartum). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03024645, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in